Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Ken Koshiba"'
Autor:
Ken Koshiba, Masahiko Taniguchi, Ryuta Suzuki, Masanori Hatashita, Kimiye Baba, Sachiko Hayashi, Takefumi Sato, Yutaka Jujo
Publikováno v:
International Journal of Molecular Medicine. 33:406-414
Sinodielide A (SA) is a naturally occurring guaianolide, which is isolated from the root of Sinodielsia yunnanensis. This root, commonly found in Yunnan province, is used in traditional Chinese medicine as an antipyretic, analgesic and diaphoretic ag
Autor:
Masahiro Aihara, Yutaka Jujo, Ken Koshiba, Tadao Endo, Masayuki Katsuta, Osamu Hoshiai, Hirotaka Nakajo, Ryuta Suzuki
Publikováno v:
The Japanese Journal of Urology. 97:575-582
PURPOSE The 2nd generation transurethral microwave thermotherapy (TUMT), equipped with high energy microwave generator and urethral cooling device is widely accepted as an less invasive effective modality to treat benign prostatic hyperplasia. For pr
Autor:
Teruaki Ao, Kazuho Suyama, Hidetoshi Kuruma, Ken Koshiba, Norihiko Okuno, Hideyuki Mizoguchi, Tadashi Motoori, Masakazu Murayama
Publikováno v:
The Japanese Journal of Urology. 92:624-627
A 70 year-old male was seen at the hospital with the chief complaints of frequent miction and incomplete urinary retention. A hen's egg-sized firm mass was palpable in anterior wall of rectum by digital rectal examination. Intravenous urography showe
Publikováno v:
The Japanese Journal of Urology. 91:645-648
Two cases of carcinoma developed in vesical diverticulum were encountered. Both these males, the first, 66-year-old and the second case, 68-year-old gentleman, visited our clinic with a complaint of asymptomatic gross hematuria. Total cystectomy was
Autor:
Takefumi Sato, Toyoaki Uchida, Ken Koshiba, Akira Irie, Makoto Ohori, Jiang-Ping Gao, Rikiya Takashima, Chunxi Wang
Publikováno v:
International Journal of Cancer. 84:19-23
The tumor suppressor gene BRCA1 on chromosome 17q21 has been characterized and shown to be mutated in patients with familial breast and ovarian cancer. Several studies examined the relatives of women with breast cancer and noted an association with o
Autor:
Masatsugu Iwamura, Makoto Ohori, Toyoaki Uchida, Teruaki Ao, Takefumi Sato, Shigehiro Soh, Ken Koshiba
Publikováno v:
Urology. 53:98-104
Objectives. Transurethral resection of the prostate (TURP) has become the primary method to relieve bladder outlet obstruction for patients with benign prostatic hyperplasia (BPH). Data from 3861 consecutive patients with BPH who underwent TURP from
Autor:
Ken Koshiba, Takefumi Satou, Sadahito Kuwao, Masatsugu Iwamura, Shin Egawa, Kazumasa Matsumoto, Kazuho Suyama
Publikováno v:
The Japanese Journal of Urology. 90:41-48
BACKGROUND: Many men with clinically suspicious findings would not be diagnosed to have prostate cancer. Establishing criteria for indicating repeat biopsy is imperative for early detection of prostate cancer. METHODS: Eighty-one patients underwent r
Autor:
Yoichi Arai, Shin Egawa, Hidetoshi Yamanaka, Kyoichi Imai, Manabu Kuriyama, Ken Koshiba, Yukimichi Kawada, Hiroshi Maeda
Publikováno v:
Japanese Journal of Clinical Oncology. 28:661-665
Background: The ratio of free PSAin total PSA(fit) has been reported to improve the diagnostic accuracy of prostate cancer in the groupwith slightly elevated serum PSA values. In Japanese cases, the clinical significance of fit is still controversial
Autor:
Masatsugu Iwamura, Kazunari Yoshida, Ken Koshiba, Shin Egawa, Kazumasa Matsumoto, Sadahito Kuwao
Publikováno v:
Japanese Journal of Clinical Oncology. 28:666-672
Background: We review the outcomes of ultrasound-guided biopsy in consecutive patients and assess clinical significance of Japanese prostate cancer. Methods: Examination was made of 1469patients subsequent to transrectal ultrasound-guided biopsyof th
Autor:
Ken Koshiba, Masatoshi Muramoto, Shin Egawa, Hisataka Kyunou, Masatsugu Iwamura, Toyoaki Uchida
Publikováno v:
Urology. 52:66-71
Objectives. To preliminarily summarize the clinical outcomes of the transrectal high-intensity focused ultrasound procedure using the prototype Sonablate (HIFU1) and the new Sonablate-200 (HIFU2) for treating symptomatic benign prostatic hyperplasia.